| Ubrelvy (ubrogepant) / AbbVie |
NCT05264129: Study to Assess Adverse Events When Ubrogepant Tablets in Combination With Atogepant Tablets Are Used to Treat Adult Participants With Migraine |
|
|
| Completed | 4 | 263 | US | Atogepant, QULIPTA, Ubrogepant, UBRELVY | AbbVie | Episodic Migraine | 04/23 | 04/23 | | |
| Active, not recruiting | 4 | 164 | US | Ubrogepant 50 MG [Ubrelvy], Ubrogepant 100 MG [Ubrelvy] | Chicago Headache Center & Research Institute, AbbVie | Headache, Migraine | 09/24 | 11/24 | | |
ATOM, NCT05214001: Evaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine |
|
|
| Recruiting | 4 | 645 | Europe | Almotriptan 12.5 Mg Oral Tablet, Almogran, Ubrogepant 50Mg Tab, Ubrelvy | Messoud Ashina, MD | Migraine With Aura, Migraine Without Aura | 12/24 | 12/25 | | |
UBRO MM, NCT06417775: Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine |
|
|
| Recruiting | 3 | 450 | US | Ubrogepant, UBRELVY, Placebo for Ubrogepant | AbbVie | Migraine | 09/27 | 09/27 | | |
NCT05125302: Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17) |
|
|
| Recruiting | 3 | 1059 | US | Ubrogepant, Ubrelvy, Placebo-Matching Ubrogepant | AbbVie | Migraine | 05/26 | 05/26 | | |
NCT05127954: Long-term Extension Study to Assess Safety and Tolerability of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Pediatric Participants (Ages 6-17) |
|
|
| Enrolling by invitation | 3 | 1200 | US | Ubrogepant, Ubrelvy | AbbVie | Migraine | 05/27 | 05/27 | | |
NCT05895500: Evaluate the Safety and Efficacy of Calcitonin Gene-Related Peptide (CGRP) Antagonists in Patients With Dry Eye Disease and Asthenopia |
|
|
| Completed | 2a | 103 | US | Injection for SC administration (120mg/syringe), Tablet (50mg/tablet), oral | Nvision Laser Eye Centers | Dry Eye, Asthenopia | 11/23 | 11/23 | | |
NCT05892757: Study to Assess Adverse Events and Compare How Oral Ubrogepant and Oral Atogepant Moves Through the Body of Healthy Female Adult Volunteers |
|
|
| Completed | 1 | 24 | US | Atogepant, QULIPTA, Ubrogepant, UBRELVY | AbbVie | Healthy Volunteers | 02/24 | 02/24 | | |
NCT06578585: A Trial Investigating Lu AG09222 With Ubrogepant in Participants With Migraine |
|
|
| Recruiting | 1 | 40 | US | Ubrogepant, Lu AG09222, Placebo | H. Lundbeck A/S | Migraine | 06/25 | 07/25 | | |
NCT05654298: Influence of Ubrogepant and Sumatriptan on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin |
|
|
| Completed | N/A | 20 | Europe | Sumatriptan, Ubrogepant | Universitaire Ziekenhuizen KU Leuven | Migraine | 03/23 | 03/23 | | |
NCT06212661: Migraine Medication Effects on Urinary Symptoms |
|
|
| Enrolling by invitation | N/A | 200 | US | Ubrogepant, Ubrelvy, Rimegepant, Nurtec, Atogepant, Qulipta, Eptinezumab, Vyepti, Fremanezumab, Ajovy, Galcanezumab, Emgality, Erenumab, Aimovig, Botulinum toxin A, Botox | The Cleveland Clinic | Overactive Bladder, Bladder Pain Syndrome, Migraine Disorders, Overactive Bladder Syndrome, Overactive Detrusor, Migraine, Interstitial Cystitis | 05/25 | 05/26 | | |
COURAGE II, NCT05653986: An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult Participants |
|
|
| Completed | N/A | 391 | US | | AbbVie | Migraine | 08/24 | 08/24 | | |
NCT06692881: Study to Assess Function and Satisfaction of Oral Ubrogepant in Adult Participants After Multiple Migraine Attacks In Canada |
|
|
| Not yet recruiting | N/A | 167 | NA | | AbbVie | Migraine | 01/26 | 01/26 | | |
COBRA, NCT05827887: An Observational Study to Assess Ubrogepant Tablets and Atogepant Tablets to Treat Migraine in Adult Participants |
|
|
| Recruiting | N/A | 200 | RoW | | AbbVie | Migraine | 09/25 | 09/25 | | |
NCT05158894: Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy |
|
|
| Recruiting | N/A | 1884 | US | | AbbVie | Migraine | 09/34 | 09/34 | | |
